PHOENIX, Ariz., April 20 (SEND2PRESS NEWSWIRE) — Business & Decision is one of the few companies to achieve certification on the Oracle Accelerators for Life Sciences. These accelerators will help life sciences companies accelerate time to market to drive profitable innovation, and optimize the demand chain to deliver quality product to customers under constant pressure to reduce costs and meet regulatory requirements.
Business & Decision has evolved the Standard Oracle Business Accelerator solution for Life Sciences and developed its own Life Sciences Accelerator solution. We have more closely defined the foundation functionality needed in Oracle’s standard E-Business Suite Business Flow Accelerators and incorporated the solution into our regulated approach and methodology. The Business & Decision solution includes Validation and Compliance Accelerator Templates. This has resulted in the creation of a comprehensive business solution for rapidly growing pharmaceutical, biotechnology and medical device companies.
The standard solution from Business & Decision includes the following software extensions and services:
• Configuration of the Oracle E-Business Suite using the Oracle Business Accelerator Process Flows to meet sector and regulatory specific requirements,
• Five customer specific forms,
• Eleven data conversions,
• Full documentation in accordance with regulatory / validation requirements (e.g. Quality Plan, User Requirements / Functional Specifications, Test Scenarios and Template Test Scripts etc),
• Document templates for client use (e.g. Validation Plan and Report, User Acceptance Test Plan, etc.).
Business & Decision is a Global Oracle Platinum Partner for Oracle E-Business Suite. This is the highest level of partnership and acknowledges our long relationship with Oracle, our international implementation capabilities and the depth of experience implementing Oracle E-Business Suite in the life sciences industry.
With 20+ years of experience in the life sciences industry Business & Decision understands sector specific business needs and uses Oracle Business Accelerators as a starting point to deliver cost-effective, accelerated ERP implementations that are appropriate to each client’s business model, product profiles / classes and regulated markets.
About Business & Decision:
Business & Decision is an international Consulting and Systems Integration (CSI) company. B&D is a leader in Enterprise Resource Planning (ERP), Business Intelligence (BI) and Customer Relationship Management (CRM), and a major player in e-Business and Enterprise Information Management (EIM). Business & Decision contributes to the success of customer projects by driving maximum business performance. The company has a reputation for functional and technological expertise and has forged partnerships with all of the key technology vendors. Located in 19 countries, Business & Decision currently employs more than 2,700 people worldwide.
Additional information is available at www.businessdecision.us.
News issued by: Business and Decision, Inc.
Original Image: https://www.send2press.com/mediaboom/10-0205-BusDecis_72dpi.jpg
# # #
Original Story ID: (5869) :: 2010-04-0420-002
Original Keywords: help life sciences companies accelerate time to market to drive profitable innovation, Business and Decision Life Sciences Accelerator solution, international Consulting and Systems Integration company, Oracle Accelerators for Life Sciences, E-Business Suite Business Flow Business and Decision, Inc. Phoenix Arizona PHOENIX, Ariz.
Alternate Headline: Business and Decision Achieves Oracle Accelerators for Life Sciences Certification
NEWS ARCHIVE NOTE: this archival news content, issued by the news source via Send2Press Newswire, was originally located in the Send2Press® 2004-2015 2.0 news platform and has been permanently converted/moved (and redirected) into our 3.0 platform. Also note the story “reads” counter (bottom of page) does not include any data prior to Oct. 30, 2016. This press release was originally published/issued: Tue, 20 Apr 2010 13:48:15 +0000
News Source: Business and Decision, Inc.